Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- EBAUGH F. G., Jr, EMERSON C. P., ROSS J. F. The use of radioactive chromium 51 as an erythrocyte tagging agent for the determination or red cell survival in vivo. J Clin Invest. 1953 Dec;32(12):1260–1276. doi: 10.1172/JCI102855. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FALCO E. A., GOODWIN L. G., HITCHINGS G. H., ROLLO I. M., RUSSELL P. B. 2:4-diaminopyrimidines- a new series of antimalarials. Br J Pharmacol Chemother. 1951 Jun;6(2):185–200. doi: 10.1111/j.1476-5381.1951.tb00634.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ISAACS R. Treatment of polycythemia vera with daraprim. J Am Med Assoc. 1954 Dec 18;156(16):1491–1493. doi: 10.1001/jama.1954.02950160021006. [DOI] [PubMed] [Google Scholar]
- SCHMIDT L. H., HUGHES H. B., SCHMIDT I. G. The pharmacological properties of 2, 4-diamino-5-p-chlorophenyl-6-ethylpyrimidine, daraprim. J Pharmacol Exp Ther. 1953 Jan;107(1):92–130. [PubMed] [Google Scholar]
- VINCKE I., LIPS M. Note sur la prophylaxie medicamenteuse par daraprim en milieu rural. An Inst Med Trop (Lisb) 1952 Jun;9(2):563–569. [PubMed] [Google Scholar]
- WETHERLEY-MEIN G., HUTT M. S., LANGMEAD W. A., HILL M. J. Radioactive iron studies in routine haematological practice. Br Med J. 1956 Jun 23;1(4981):1445–1449. doi: 10.1136/bmj.1.4981.1445. [DOI] [PMC free article] [PubMed] [Google Scholar]
